BCYCBicycle Therapeutics PLC

3.65−4.34%· post 3.65

Mkt cap$256.5MRevenue$34MQ3 FY26Revenue$73MFY25

VYGRVoyager Therapeutics, Inc.

1.72−2.52%· post 1.72

ClosedOct 30 '26

Mkt cap$106.0MRevenue$3MQ2 FY26Revenue$40MFY25

Compare

ClosedOct 30 '26

BCYCBicycle Therapeutics PLC

VYGRVoyager Therapeutics, Inc.

3.65−4.34%post 3.65

Price

1.72−2.52%post 1.72

$256.5M

Mkt cap

$106.0M

Q3 FY26$34M

Revenue

$3MQ2 FY26

FY25$73M

Revenue

$40MFY25

BCYCBicycle Therapeutics PLC

Mkt capRevenueRevenue

VYGRVoyager Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

BCYCBicycle Therapeutics PLC

VYGRVoyager Therapeutics, Inc.

Price

Mkt cap

Revenue

Save comparison

Earnings history

last 4 reports each · paired by recencyMethod

BCYC1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±22.5%−1.55%×0.07

VYGR

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±50.5%+4.47%×0.09

May 8 '26±32.6%+2.27%×0.07

Q1 FY26—+21.65%—

Nov 10 '25±71.8%+0.71%×0.01

= impliedBCYC realized, solidVYGR realized, hatchedOne scale, both sides: full bar = 72%× = |realized| ÷ impliedSource: market data

BCYC compared with VYGR: revenue, margins and what each company keeps, and the suppliers and customers both name

Earnings history

Earnings history

Earnings history